Krystal Biotech (KRYS) Capital Expenditures (QoQ) (2017 - 2026)
Krystal Biotech (KRYS) Capital Expenditures (QoQ) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Krystal Biotech | 9.59 Bn | 8.77 Bn | 110.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.47% |
| Dec 31, 2025 | 446.18% |
| Sep 30, 2025 | 85.52% |
| Jun 30, 2025 | -178.58% |
| Mar 31, 2025 | 22.61% |
| Dec 31, 2024 | 198.62% |
| Sep 30, 2024 | -170.21% |
| Jun 30, 2024 | 480.00% |
| Mar 31, 2024 | -85.27% |
| Dec 31, 2023 | 205.31% |
| Sep 30, 2023 | -119.90% |
| Jun 30, 2023 | -131.13% |
| Mar 31, 2023 | -20.35% |
| Dec 31, 2022 | 167.09% |
| Sep 30, 2022 | -199.82% |
| Jun 30, 2022 | 247,244.44% |
| Mar 31, 2022 | 99.96% |
| Dec 31, 2021 | -238.96% |
| Sep 30, 2021 | 335.43% |
| Jun 30, 2021 | 47.11% |